SVA

Sinovac Biotech, Ltd
SVA

Overview Fund Activity
Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

3 hedge funds and large institutions have $336M invested in Sinovac Biotech, Ltd in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.04%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
O
1
OrbiMed
New York
$334M 2,718,735 – –
NAH
2
Neumann Advisory (HK)
Hong Kong
$2.04M 315,586 – –
NA
3
Navellier & Associates
Nevada
– – -14,167 Closed
CFGS
4
Concourse Financial Group Securities
Alabama
– – – –
FGAM
5
Financial Gravity Asset Management
Texas
$0 23 +23 New